<SEC-DOCUMENT>0001213900-25-094519.txt : 20251001
<SEC-HEADER>0001213900-25-094519.hdr.sgml : 20251001
<ACCEPTANCE-DATETIME>20251001125116
ACCESSION NUMBER:		0001213900-25-094519
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251001
DATE AS OF CHANGE:		20251001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAFE & GREEN HOLDINGS CORP.
		CENTRAL INDEX KEY:			0001023994
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS [5030]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				954463937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286850
		FILM NUMBER:		251363537

	BUSINESS ADDRESS:	
		STREET 1:		195 MONTAGUE STREET, 14TH FLOOR
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11201
		BUSINESS PHONE:		(646) 240-4235

	MAIL ADDRESS:	
		STREET 1:		195 MONTAGUE STREET, 14TH FLOOR
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SG BLOCKS, INC.
		DATE OF NAME CHANGE:	20111122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CDSI HOLDINGS INC
		DATE OF NAME CHANGE:	19990114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PC411 INC
		DATE OF NAME CHANGE:	19961001
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>ea0259732-424b3_safeandgreen.htm
<DESCRIPTION>PROSPECTUS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-align: right; text-indent: 0.5in"><B>Registration No. 333-286850</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="width: 120px; height: 119px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Safe&nbsp;&amp;
Green Holdings Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>937,500 Shares
of Common Stock</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus relates to the resale
from time to time by the selling stockholder (the &ldquo;Selling Stockholder&rdquo;) identified in this prospectus under the caption
&ldquo;Selling Stockholder&rdquo; of up to 937,500 shares of our Common Stock, par value $0.01 (our &ldquo;Common Stock&rdquo;),
underlying the Series B Convertible Preferred Stock (the &ldquo;<U>Shares</U>&rdquo;), issuable upon conversion of the 60,000 shares
of our Series B Convertible Preferred Stock, par value $0.01 (the &ldquo;<U>Series B Preferred Stock</U>&rdquo;) issued to the
Selling Stockholders pursuant to an Exchange Agreement (the &ldquo;<U>Exchange Agreement</U>&rdquo;) by and among the Company and
the Investors. The amount of Series B Preferred Stock is multiplied by the Stated Value (as defined below), which equals 937,500
(60,000,000 pre-Reverse Stock Split), and then divided by the Floor price of $0.20, which equals 4,687,500 shares (post-Reverse
Stock Split), of which we are registering 937,500 shares herein (post-Reverse Stock Split). Pursuant to the Exchange Agreement, the
parties effected a voluntary security exchange transaction (the &ldquo;<U>Transaction</U>&rdquo;) whereby the Investors exchanged
the Series A and Series B Warrants previously purchased in the April 14, 2025 private placement (the &ldquo;April 2025 Private
Placement&rdquo;) for an aggregate of 60,000 shares of Series B Preferred Stock (the &ldquo;<U>Exchange Shares</U>&rdquo;), with the
New Series B Convertible Preferred Stock&rsquo;s rights and preferences being set forth on that certain certificate of designation
filed in our current report on Form 8-K filed with the SEC on July 18, 2025.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">We did not receive
any proceeds from the Exchange Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">We will not receive
any proceeds from the sale of the Registrable Securities by the Selling Stockholder under this prospectus. We provide more information
about how we plan to use the proceeds in the section titled &ldquo;Use of Proceeds&rdquo; on page 15 of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Shares were
offered and sold by us pursuant to the exemption provided by Section 3(a)(9) of the Securities Act and Regulation D promulgated thereunder.
We are registering the offer and resale of the Registrable Securities to satisfy the provisions of that certain registration rights agreement,
dated July 17, 2025 (the &ldquo;Registration Rights Agreement&rdquo;), pursuant to which we agreed to register the resale of the Shares.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The foregoing summaries
of the Exchange Agreement and the Registration Rights Agreement do not purport to be complete and are qualified in their entirety by
the Exchange Agreement and the Registration Rights Agreement attached as Exhibits 10.1 and 10.2, respectively, to our Current Report
on Form 8-K filed with the SEC on July 18, 2025, each of which is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Selling Stockholder
may sell its Shares underlying the Series B Preferred Stock described in this prospectus in a number of different ways and at varying
prices. We provide more information about how the Selling Stockholder may sell its shares underlying the Series B Preferred Stock in
the section titled &ldquo;Plan of Distribution&rdquo; on page 18 of this prospectus. We will pay the expenses incurred in registering
the securities covered by this prospectus, including legal and accounting fees. To the extent the Selling Stockholder decides to sell
any of its Shares underlying the Series B Preferred Stock, we will not control or determine the price at which the shares are sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is listed on the Nasdaq Capital Market under the symbol
&ldquo;SGBX&rdquo;. On September 30, 2025, the last reported sale price of our Common Stock on the Nasdaq Capital Market was $7.18 per
share. We urge prospective purchasers of our Common Stock to obtain current information about the market prices of our Common Stock.
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Investing in
our securities involves significant risks, including those set forth in the &ldquo;Risk Factors&rdquo; section of this prospectus beginning
on page 11 and in our filings with the Securities and Exchange Commission (referred to herein as the &ldquo;Securities and Exchange Commission&rdquo;
or the &ldquo;SEC&rdquo;).</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Neither the
Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon
the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is October 1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 90%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 9%"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><A HREF="#a_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><A HREF="#a_002"><FONT STYLE="font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><A HREF="#a_003"><FONT STYLE="font-size: 10pt">THE OFFERING</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><A HREF="#a_004"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">11</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><A HREF="#a_005"><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><A HREF="#a_006"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><A HREF="#a_007"><FONT STYLE="font-size: 10pt">SECURITY OWNERSHIP OF CERTAIN BENFICIAL OWNERS AND MANAGEMENT</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><A HREF="#a_008"><FONT STYLE="font-size: 10pt">SELLING STOCKHOLDER</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><A HREF="#a_009"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><A HREF="#a_010"><FONT STYLE="font-size: 10pt">DESCRIPTION OF OUR SECURITIES</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><A HREF="#a_011"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><A HREF="#a_012"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><A HREF="#a_013"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND ADDITIONAL INFORMATION</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><A HREF="#a_014"><FONT STYLE="font-size: 10pt">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration statement containing this prospectus,
including the exhibits to the registration statement, provides additional information about us and the Common Stock offered under this
prospectus. The registration statement, including the exhibits, can be read on our website and the website of the Securities and Exchange
Commission. See &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information contained in, and that can be accessed
through our web site, <I>www.safeandgreenholdings.com</I>, shall not be deemed to be part of this prospectus or incorporated herein by
reference and should not be relied upon by any prospective investors for the purposes of determining whether to purchase the Common Stock
offered hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless the context otherwise requires, the terms
&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;the Company,&rdquo; &ldquo;Safe&nbsp;&amp; Green,&rdquo; the &ldquo;Registrant&rdquo;,
and &ldquo;our business&rdquo; refer to Safe&nbsp;&amp; Green Holdings Corp., and &ldquo;this offering&rdquo; refers to the offering
contemplated in this prospectus of the Registrable Securities.</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_001"></A>About
this Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the Selling Stockholder nor we have authorized
anyone to provide you with any information or to make any representations other than those contained in this prospectus, any post-effective
amendment, or any applicable prospectus supplement prepared by or on behalf of us or to which we have referred you. We and the Selling
Stockholder take no responsibility for and can provide no assurance as to the reliability of any other information that others may give
you. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where
it is lawful to do so. The information contained in this prospectus is current only as of the date on the front cover of the prospectus.
Our business, financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains summaries of certain
provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information.
All of the summaries are qualified in their entirety by the full text of the actual documents. Copies of some of the documents referred
to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this
prospectus is a part, as described in &ldquo;Incorporation of Certain Documents by Reference&rdquo; in this prospectus, and you may obtain
copies of those documents as described below under the section entitled &ldquo;Where You Can Find More Information.&rdquo; We further
note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that
is incorporated by reference into this prospectus were made solely for the benefit of the parties to such agreement, including, in some
cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty
or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly,
such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Industry and Market Data</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, information in this
prospectus concerning economic conditions, our industry, our markets and our competitive position is based on a variety of sources, including
information from third-party industry analysts and publications and our own estimates and research. This information involves a number
of assumptions, estimates and limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The industry publications, surveys and forecasts
and other public information generally indicate or suggest that their information has been obtained from sources believed to be reliable.
We believe this information is reliable as of the applicable date of its publication; however, we have not independently verified the
accuracy or completeness of the information included in or assumptions relied on in these third-party publications. In addition, the
market and industry data and forecasts that may be included in this prospectus, any post-effective amendment or any prospectus supplement
may involve estimates, assumptions and other risks and uncertainties and are subject to change based on various factors, including those
discussed under the heading &ldquo;Risk Factors&rdquo; contained in this prospectus, any post-effective amendment and the applicable
prospectus supplement. Accordingly, investors should not place undue reliance on this information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Trademarks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains references to our trademarks
and service marks and to those belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus
may appear without the <SUP>&reg;</SUP> or &trade; symbols, but such references are not intended to indicate, in any way, that we will
not assert, to the fullest extent possible under applicable law, our rights or the rights of the applicable licensor to these trademarks
and trade names. We do not intend our use or display of other companies&rsquo; trade names, trademarks or service marks to imply a relationship
with, or endorsement or sponsorship of us by any other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Smaller Reporting Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a &ldquo;smaller reporting company&rdquo;
under applicable Securities and Exchange Commission rules and, as such, have elected to comply with certain reduced public company disclosure
requirements for this prospectus and future filings. See &ldquo;Prospectus Summary&nbsp;&mdash;&nbsp;Smaller Reporting Company&rdquo;
for additional information.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_002"></A><FONT STYLE="text-transform: uppercase"><B>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This summary highlights certain information
appearing elsewhere in this prospectus. Because it is only a summary, it does not contain all of the information that you should consider
before investing in our securities and it is qualified in its entirety by, and should be read in conjunction with, the more detailed
information appearing elsewhere in this prospectus. Before you decide to invest in our securities, you should read the entire prospectus
carefully, including &ldquo;Risk Factors&rdquo; beginning on page 11 and the financial statements and related notes included in this
prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We were incorporated in the State of Delaware
on December&nbsp;29, 1993 under the name PC411, INC.&nbsp;On January&nbsp;12, 1999, we changed our name to CDSI Holdings, Inc. On November&nbsp;4,
2011, CDSI Merger Sub, Inc., our wholly owned subsidiary, completed a reverse merger with and into SG Building Blocks, Inc. (&ldquo;SG
Building&rdquo;), with SG Building surviving the reverse merger as our wholly owned subsidiary. Also on November&nbsp;4, 2011, we changed
our name to SG Blocks, Inc. On December&nbsp;16, 2022, we changed our name to Safe&nbsp;&amp; Green Holdings Corp. In addition, on December&nbsp;16,
2022, our then wholly-owned&nbsp;subsidiary, SGB Development Corp. changed our name to Safe and Green Development Corporation by filing
a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware. Prior to our emergence
from bankruptcy in June&nbsp;2016, our Common Stock was quoted on the OTC Bulletin Board. Our Common Stock is currently listed for trading
on the Nasdaq Capital Market under the symbol &ldquo;SGBX.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our principal offices are located at 990 Biscayne
Blvd, #501, Office&nbsp;12, Miami, Florida 33132. Our website address is&nbsp;<I>www.safeandgreeenholdings.com.&nbsp;</I>The information
contained in, and that can be accessed through our website, is not incorporated into and is not a part of this prospectus. Our phone
number is (646)&nbsp;240-4235.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Business Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We operate in the following four segments: (i)&nbsp;manufacturing
and construction services; (ii)&nbsp;medical; (iii)&nbsp;real estate development; and (iv)&nbsp;environmental. The manufacturing and
construction segment designs and manufactures modular structures built in our factories using raw materials that are Made-in-America.
In the medical segment we have previously used our modular technology to offer prefabricated health facilities for on-site&nbsp;immediate
COVID-19&nbsp;testing and plan to provide our modular technology to offer turnkey solutions to medical testing and treatment and generating
revenue from medical testing. Our real estate development segment&rsquo;s current business focus is primarily on the direct acquisition
and indirect investment in properties nationally that will be further developed in the future into green single or multi-family&nbsp;projects.
The environmental segment, the newest segment, plans to offer a sustainable medical and waste management solution that will utilize a
patented technology to collect waste and treat waste for safe disposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a provider of modular facilities (&ldquo;Modules&rdquo;).
We currently provide Modules made out of both code-engineered&nbsp;cargo shipping containers and traditional construction using wood
and steel framing for use as both permanent or temporary structures for residential housing use and commercial use. Prior to the COVID-19&nbsp;pandemic,
the Modules we supplied were primarily for retail, restaurant and military use and were manufactured by third party suppliers using our
proprietary technology and design and engineering expertise, which modifies code-engineered&nbsp;cargo shipping containers and purpose-built&nbsp;modules
for use for safe and sustainable commercial, industrial and residential building. In March&nbsp;2020, in response to the COVID-19&nbsp;pandemic
we began increasing our focus on providing our Modules as health care facilities for deployable medical response solutions. In September&nbsp;2020,
we acquired substantially all the assets of Echo DCL, LLC, a Texas limited liability company (&ldquo;Echo&rdquo;), except for Echo&rsquo;s
real estate holdings. Echo was a container/modular manufacturer based in Durant, Oklahoma specializing in the design and construction
of permanent modular and temporary modular buildings and was one of our key supply chain partners. This acquisition allowed us to have
more control over the manufacturing process and, as a result, we have increased our product offerings to add Modules made out of wood,
steel and traditional construction materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2021, through our former subsidiary, Safe
and Green Development Corporation. (&ldquo;SG DevCorp&rdquo; or &ldquo;SG Development&rdquo;) we also began to focus on acquiring property
to build multi-family&nbsp;housing projects in underserved regions utilizing the manufacturing services of our subsidiary SG Echo, LLC
(&ldquo;SG Echo&rdquo;). In March&nbsp;2022, we formed SG Environmental Solutions Corp. (&ldquo;SG Environmental&rdquo;) to focus on
biomedical waste removal utilizing a patented technology that it licenses to shred and disinfect biomedical waste, rendering the waste
disinfected, unrecognizable, and of no greater risk to the public health than residential household waste. In March&nbsp;2023, we formed
Safe and Green Medical Corporation (&ldquo;SG Medical&rdquo;), to focus on providing our Modules as health care facilities with various
clinics and labs that cater to the specific needs of local communities. To date, we have not generated revenue from SG Environmental
or SG Medical.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> During&nbsp;2024, our ownership in SG
DevCorp fell below&nbsp;50%, and we deconsolidated SG DevCorp from our financial statements (the &ldquo;Deconsolidation&rdquo;). The
decrease in ownership percentage resulted from additional equity transactions of SG DevCorp. The Deconsolidation represents a strategic
shift in our operations and will have a major effect on our operations and financial results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>June Line of Credit</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On June 3, 2025 (the &ldquo;Effective
Date&rdquo;), Olenox Corp. (the &ldquo;Borrower&rdquo;), a wholly owned subsidiary of Safe &amp; Green Holdings Corp. (the &ldquo;Company&rdquo;),
entered into a Promissory Note (the &ldquo;Note&rdquo;) in favor of Prosperity Bank (the &ldquo;Lender&rdquo;) in the aggregate principal
amount of $2,000,000 (the &ldquo;Principal&rdquo;). The Note evidences a revolving Line of Credit of Olenox with the Lender. After all
loan processing and origination fees of $15,002, the Borrower received net loan proceeds of $1,984,998. The Note is secured by the Company&rsquo;s
Certificate of Deposit held with the Lender with an approximate balance of $2,000,000 </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Note shall bear interest at a rate
of five percent (5%) per annum. Interest shall be calculated based on a year of 360 days. The Note shall be due in full immediately upon
Lender&rsquo;s demand. If no demand is made, Borrower will pay all outstanding principal and all accrued unpaid interest on June 2, 2026.
In addition, the Borrower will pay regular monthly payments of all accrued interest due as of each payment date, beginning July 2, 2025.
The Borrower may prepay all or a portion of the principal without penalty earlier than it is due. If a payment is 10 days or more late,
the Borrower will be charged a late charge 5.00% of the unpaid portion of the regular payment. The Lender reserves a right of setoff
in all of the Borrower&rsquo;s accounts with the Lender (whether checking, savings, or some other account). The Borrower authorizes the
Lender, to the extent permitted by applicable law, to charge or setoff all sums owing on the indebtedness against any and all such accounts.
The Note provides for a commercial guaranty by Michael McLaren. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Among others, the following shall constitute
an event of default under the Note (each an &ldquo;Event of Default&rdquo;): if the Borrower fails to make any payment when due under
the Note; if the Borrower fails to comply with or to perform any other term, obligation, covenant, or condition contained in the Note
or any related documents; any representation or statement made by the Borrower to the Lender is false or misleading in any material respect;
a change in ownership of twenty-five percent (25%) or more of the common stock of the Borrower; or a material adverse change in the Borrower&rsquo;s
financial condition. Upon an Event of Default, the interest rate on the Note shall be 18.00%. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Note contains covenants applicable
to the Borrower pertaining to the line of credit, including, among others, that the Borrower agrees to: maintain books and records of
its operations (the &ldquo;Books and Records&rdquo;) to the need for the line of credit; permit the Lender or any of the Lender&rsquo;s
representatives, inspect and/or copy the Books and Records; and to provide the Lender any documentation requested which support the reason
for making any advance under the line of credit. Further, the Note provides that the Borrower shall furnish from time to time to the
Lender, upon the Lender&rsquo;s request, copies of balance sheets of the Borrower, and copies of statements of income and cash flows
of the Borrower. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <U>May Equity Line of Credit</U> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On May 29, 2025 (the &ldquo;Effective
Date&rdquo;), Safe &amp; Green Holdings Corp. (the &ldquo;Company&rdquo;) entered into a Stock Purchase Agreement (the &ldquo;ELOC Purchase
Agreement&rdquo;) with Generating Alpha Ltd., a Saint Kitts and Nevis Company (the &ldquo;Purchaser&rdquo;), whereby the Company shall
issue and sell to the Purchaser, subject to the terms and conditions of the ELOC Purchase Agreement, up to an aggregate of $100 million
(the &ldquo;Commitment Amount&rdquo;) of newly issued shares (the &ldquo;ELOC Shares&rdquo;) of the Company&rsquo;s common stock, par
value $0.01 per share (the &ldquo;Common Stock&rdquo;). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company does not have a right to commence
any sales of Common Stock to the ELOC Purchaser under the ELOC Purchase Agreement until the time when all of the conditions to the Company&rsquo;s
right to commence sales of Common Stock to the ELOC Purchaser set forth in the ELOC Purchase Agreement have been satisfied, including
that a registration statement of such shares is declared effective by the SEC and the final form of prospectus is filed with the SEC
(the &ldquo;Commencement Date&rdquo;). Over the period ending on the earlier of May 8, 2026, or the date on which the Purchaser shall
have purchased ELOC Shares pursuant to the ELOC Purchase Agreement for an aggregate purchase price of the Commitment Amount, the Company
will control the timing and amount of any sales of ELOC Shares to the ELOC Purchaser. Actual sales of shares of Common Stock to the ELOC
Purchaser under the ELOC Purchaser Agreement will depend on a variety of factors to be determined by the Company from time to time, including,
among others, market conditions, the trading price of the Common Stock and determinations made by the Company as to appropriate sources
of funding. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
</DIV>
<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The purchase price of the shares of ELOC
Shares that the Company elects to sell to the ELOC Purchaser pursuant to the ELOC Purchase Agreement will be equal to the lowest traded
price of Common Stock during the seven (7) trading days prior to the applicable closing date multiplied by 90%. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In no event may the Company issue to the
ELOC Purchaser under the ELOC Purchase Agreement more than the 4.99% of the total number of the Company&rsquo;s shares of Common Stock
issued and outstanding immediately prior to the execution of the ELOC Purchase Agreement (the &ldquo;Applicable Exchange Cap&rdquo;),
unless the Company obtains stockholder approval to issue shares of Common Stock in excess of the Applicable Exchange Cap. In any event,
the ELOC Purchase Agreement provides that the Company may not issue or sell any shares of Common Stock under the ELOC Purchase Agreement
if such issuance or sale would breach any applicable Nasdaq rules. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The ELOC Purchase Agreement prohibits
the Company from directing the Company to purchase any shares of Common Stock if those shares, when aggregated with all other shares
of Common Stock then beneficially owned by the ELOC Purchaser (as calculated pursuant to Section 13(d) of the Securities Exchange Act
of 1934, as amended), would result in the ELOC Purchaser beneficially owning more than 4.99% of the outstanding Common Stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The ELOC Purchase Agreement provides that
the Company shall file a registration statement registering the resale of the maximum number of ELOC Shares as shall be permitted by
applicable law within ten (10) calendar days following the Effective Date of the ELOC Purchase Agreement. The Company shall use its best
efforts to have the registration statement declared &ldquo;effective&rdquo; within thirty (30) days of the date of the ELOC Purchase
Agreement, but no more than sixty (60) calendar days after the Company has filed the registration statement. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <U>Sherman Oil Asset Purchase</U> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On May 28, 2025, Safe &amp; Green Holdings
Corp. (&ldquo;the Company&rdquo;) entered into an asset purchase agreement (the &ldquo;Asset Purchase Agreement&rdquo;) with Sherman
Oil Company LLC and its affiliates (&ldquo;Sherman Oil&rdquo;), pursuant to which the Company will acquire approximately 1,600 acres
of held-by-production oil leases for oil wells located in Wichita County and Wilbarger County, Texas (the &ldquo;Assets&rdquo;) for a
purchase price of $1,000,000 (the &ldquo;Purchase Price&rdquo;). The purchase of the Assets includes Sherman Oil&rsquo;s operational
equipment of the oil wells. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the Asset Purchase Agreement,
the Company will pay the Purchase Price as follows: $250,000 in cash on the closing date, $250,000 in cash within 90 days of the closing
date, $250,000 in cash within 180 days of the closing date, and $250,000 in cash within 240 days of the closing date. The payments will
bear no interest. The Asset Purchase Agreement contains customary representations, warranties, and covenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>April Promissory Note </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 11, 2025 (the &ldquo;Issue Date&rdquo;),
Safe &amp; Green Holdings Corp. (the &ldquo;Company&rdquo;) executed and issued a Promissory Note (&ldquo;Note&rdquo;) in favor of Generating
Alpha Ltd. (the &ldquo;Lender&rdquo;) in the aggregate principal amount of $267,000 (the &ldquo;Principal&rdquo;), and an accompanying
Securities Purchase Agreement (the &ldquo;SPA&rdquo;) and Registration Rights Agreement (the &ldquo;RRA&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Note was purchased by the Lender for a purchase
price of $213,600, representing an original issue discount of $53,400. The Note shall bear interest at a rate of fifteen percent (15%)
per annum, with the understanding that the first twelve months of interest under the Node (equal to $40,050), shall be guaranteed and
earned in full as of the Issue Date. Any amount of Principal or interest due under the Note which is not paid when due shall bear interest
at eighteen percent (18%) per annum (&ldquo;Default Interest&rdquo;). The Company shall make monthly payments on the Note (each an &ldquo;Amortization
Payment&rdquo;) in the amount of $30,705, due and payable each month commencing on July 4, 2025, and ending on April 6, 2026. The Company
may accelerate the payment date of any Amortization Payment by giving notice to the Lender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
</DIV>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Company fails to pay any Amortization
Payment when due, in addition to all other rights under the Note, the Lender shall have the right to convert at any time any portion
of the Note at a price per share equal to the Market Price. &ldquo;Market Price&rdquo; shall mean the lesser of (i) the then applicable
conversion price under the Note or (ii) 80% of the lowest closing price of the Company&rsquo;s shares of common stock, par value $0.01
(&ldquo;Common Stock&rdquo;) on any trading day during the ten trading days prior to the conversion date. If an event of default occurs
under the Note, then, in addition to all other rights under the Note, the Lender shall have the right to convert at any time any portion
of the Note at a price per share equal to the Alternate Price. &ldquo;Alternate Price&rdquo; shall mean the lesser of (i) the then applicable
conversion price, (ii) the closing price of the Common Stock on the date of the event of default (provided, however, that if such date
is not a trading day, then the next trading day after the event of default), or (iii) $0.52 ($33.28 as adjusted for with the 2025 Reverse
Stock Split) (subject to adjustment as provided in the Note).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The total cumulative number of shares of Common
Stock issued to Lender under the Note, together with the SPA and RRA, may not exceed the requirements of Nasdaq Listing Rule 5635(d)
(the &ldquo;Nasdaq 19.99% Cap&rdquo;), except that is the number of shares of Common Stock issued to Lender reaches the Nasdaq 19.99%
Cap, the Company, at its election, will use reasonable commercial efforts to obtain stockholder approval of the Note and the issuance
of additional conversion shares, in accordance with the requirements of Nasdaq Listing Rule 5635(d) (the &ldquo;Approval&rdquo;). If
the Company is unable to obtain such Approval, any remaining outstanding balance of the Note must be repaid in cash.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Among others, the following shall be considered
events of default under the Note (&ldquo;Event of Default&rdquo;): if the Company fails to pay an Amortization Payment when due on the
Note; the Company fails to perform or observe any covenant, term, provision, condition, agreement, or obligation of the Company under
the Note, the SPA, or the RRA; the Company shall make an assignment for the benefit of creditors, or apply for or consent to the appointment
of a receiver or trustee for it or for a substantial part of its property or business.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">After an Event of Default, in addition to
all other rights under the Note, the Lender shall have the right to convert any portion of the Note at any time at a price per share
equal to the Alternate Price. The &ldquo;Alternate Price&rdquo; shall mean the lesser of (i) the applicable conversion price under the
Note, (ii) the closing price of the Common Stock on the date of the Event of Default, or (iii) $0.52 ($33.28 as adjusted for with the
2025 Reverse Stock Split).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">So long as the Company has any obligation under
the Note, the Company shall not, without the Lender&rsquo;s written consent: pay, declare, or set apart for such payment, any dividend
or other distribution; redeem, repurchase, or otherwise acquire any shares of capital stock the Company; repay any indebtedness of the
Company; or sell, lease, or otherwise dispose of any significant portion of the Company&rsquo;s assets outside the ordinary course of
business.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Commencing sixty (60) days after free trading
shares of Common Stock are available to the Lender, the Company may deliver a notice to the Lender (an &ldquo;Optional Redemption Notice&rdquo;)
of its election to redeem the outstanding balance together with all unpaid interest accrued thereon of the Note for cash at a redemption
price equal to: one hundred and ten percent (110%) multiplied by the then-outstanding balance together with all unpaid interest accrued
thereon of the Note. Upon receipt of the Optional Redemption Notice, the Lender shall have the option to convert up to 1/3 of the outstanding
balance of the Note at the lower of the fixed conversion price or the alternative conversion price. If a change of control occurs, an
additional 5% premium would be owed on the outstanding balance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>April 2025 Private Placement </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 14, 2025,
Safe &amp; Green Holdings Corp. (the &ldquo;Company&rdquo;) consummated the previously announced private placement (the &ldquo;Private
Placement&rdquo;) pursuant to a securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with institutional investors (the
&ldquo;Purchasers&rdquo;) for the purchase and sale of approximately $8 million of shares of the Company&rsquo;s common stock (the &ldquo;Common
Stock&rdquo;) and investor warrants at a price of $0.392 per Common Unit ($25.08 as adjusted for the 2025 Reverse Stock Split). The entire
transaction was priced at the market under Nasdaq rules. The offering consisted of the sale of Common Units (or Pre-Funded Units), each
consisting of (i) one (1) share of Common Stock or one (1) Pre-Funded Warrant, (ii) one (1) Series A PIPE Common Warrant to purchase
one (1) share of Common Stock per warrant at an exercise price of $0.784 (the &ldquo;Series A Warrant&rdquo;) and (iii) one (1) Series
B PIPE Common Warrant to purchase one (1) share of Common Stock per warrant at an exercise price of $0.98 ($62.72 as adjusted for with
the 2025 Reverse Stock Split). (the &ldquo;Series B Warrant&rdquo; and together with the Series A Warrant, the &ldquo;Warrants&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The initial exercise
price of each Series A Warrant was $0.784 per share ($50.18 as adjusted for with the 2025 Reverse Stock Split). of Common Stock. The
Series A Warrants were to be exercisable following stockholder approval and to expire five (5) years thereafter. The number of securities
issuable under the Series A Warrant were subject to adjustment as described in more detail in the Series A Warrant. The initial exercise
price of each Series B Warrant was $0.98 per share ($62.72 as adjusted for with the 2025 Reverse Stock Split). of Common Stock or pursuant
to an alternative cashless exercise option. The Series B Warrants were exercisable following stockholder approval and expire two and
one-half (2.5) years thereafter. The number of securities issuable under the Series B Warrant were subject to adjustment as described
in the Series B Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each Pre-Funded Warrant was exercisable for one share of Common Stock
for $0.0001 immediately upon issuance until all of the Pre-Funded Warrants are exercised in full. The number of Pre-Funded Warrant Shares
are subject to adjustments for stock splits, recapitalizations, and reorganizations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> The Company will
not be registering the shares underlying the Series A Warrant and Series B Warrant, as the Company has renegotiated the transaction,
to eliminate the Series A and Series B Warrants with the investors from the April Private Placement. The Series A and B Warrants have
now been exchanged, pursuant to the Exchange Agreement by and among the Company and the Investors, whereby the Investors will exchange
the Series A and Series B Warrants previously purchased in the April 14, 2025 private placement (the &ldquo;April 2025 Private Placement&rdquo;)
for an aggregate of 60,000 shares of Series B Preferred Stock (the &ldquo;<U>Exchange Shares</U>&rdquo;), with the New Series B Convertible
Preferred Stock&rsquo;s rights and preferences being set forth on that certain certificate of designation (the &ldquo;<U>Certificate
of Designation</U>&rdquo;) of the Company, filed with the State of Delaware on July 17, 2025, in substantially in the form set forth
hereto on our current report on Form 8-K, filed on July 18, 2025. The Company
is solely registering the shares underlying the Exchange Shares herein.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <U>County Line Asset Purchase</U> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On April 8, 2025 (the &ldquo;Effective
Date&rdquo;), Safe &amp; Green Holdings Corp. (the &ldquo;Company&rdquo;) has entered into an asset purchase agreement (the &ldquo;Asset
Purchase Agreement&rdquo;) with County Line Industrial LLC (&ldquo;County Line&rdquo;) to acquire all of the assets and operating business
of County Line (the &ldquo;Assets&rdquo;) for a purchase price of $1,000,000 (the &ldquo;Purchase Price&rdquo;). The acquisition of County
Line&rsquo;s business includes the acquisition of all of County Line&rsquo;s existing customers and business pipeline, and the hiring
of County Line&rsquo;s existing employees, and the hiring of County Line&rsquo;s sole member, Carter Fields. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the Asset Purchase Agreement,
the Company will pay the Purchase Price as follows: a cash payment in the amount of $125,000 due on or before April 15, 2025, a cash
payment in the amount of $100,000 due on or before May 15, 2025; a cash payment in the amount of $250,000 due on or before July 15, 2025;
and a cash payment in the amount of $525,000 due on or before January 31, 2026. The payments will bear no interest. In addition to the
Purchase Price, the Company shall pay its current payable due to County Line, in the amount of $76,000, on or before May 1, 2025. County
Line shall pay all obligations of its three vehicles for an approximate total amount of $92,000. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Asset Purchase Agreement contains
customary representations and warranties for this type of transaction, including but not limited to, County Line shall deliver all of
the Assets free and clear of all liabilities, liens, loans, and encumbrances, and shall ensure that the Assets are in good working condition,
subject to normal wear and tear. The Company shall not assume or be responsible for any of County Line&rsquo;s liabilities, debts, obligations,
whether presently existing or arising thereafter. County Line and its sole member have agreed to customary restrictive covenants including
non-competition, non-circumvention, and non-solicitation for a period of two years. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><U>NAHD
Merger</U></FONT>&nbsp;&nbsp; </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 2, 2025, the Company entered into
an Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) by and between the Company and New Asia Holdings, Inc., a Nevada
corporation (&ldquo;NAHD&rdquo;), pursuant to which NAHD will be merged into a to-be-formed subsidiary of the Company (the &ldquo;Merger&rdquo;).
Following this Merger, the NAHD operating subsidiaries will be indirect, wholly owned subsidiaries of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As merger consideration, the Company will issue
four million (4,000,000) Series A non-voting convertible preferred shares of the Company, par value $1.00 (the &ldquo;Preferred Shares&rdquo;),
to the NAHD shareholders. Each Preferred Share has the right to convert into shares of common stock of the Company at a ratio of 1 to
15 (each Preferred Share will convert into 15 shares of common stock of the Company), provided, however, that such conversion is subject
to the approval of a majority of the Company&rsquo;s common shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Merger Agreement contain customary representations,
warranties, and covenants. The Merger Agreement also contain conditions to the completion of the Merger including the filing of the articles
of incorporation and/or organization for the merger subsidiaries, and the adoption of board resolutions and/or sole member resolutions
by the merger subsidiaries approving the Merger. There are no assurances that the parties will satisfy all of the conditions to the merger.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The parties expect to complete these transactions
as soon as practicable following the satisfaction or waiver of the condition to the Merger.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the Merger, NAHD and its subsidiaries
Olenox Corp., a Nevada corporation, and Machfu Inc., a Delaware corporation, will be indirect, wholly owned subsidiaries of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of such transaction, which positively
impacts stockholders&rsquo; equity by approximately $35 million, as of the date of this filing the Company believes it has stockholders&rsquo;
equity of at least $2.5 million as required by Nasdaq Listing Rules and that this will be evidenced in the Company&rsquo;s 10-Q for the
quarterly period ended June 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of the 1:64 reverse stock split effected by the Company
on September 8, 2025, each Preferred Share will have the right to convert into shares of common stock of the Company at a ratio of 1
for 0.234375, meaning each 64 Preferred Shares will convert into 15 shares of common stock of the Company, meaning the 4,000,000 Preferred
Shares will convert into 937,500 shares of common stock of the Company, subject to approval of a majority of the Company&rsquo;s common
shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>2024</U> <U>Reverse Stock Split</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On May 2, 2024, we effected a 1-for-20 Reverse
Stock Split of our outstanding Common Stock (&ldquo;Reverse Split&rdquo;). As a result of the Reverse Split, each of our stockholders
received one new share of Common Stock for every 20 shares such stockholder held immediately prior to the effective time of the Reverse
Split. The Reverse Split affected all of our issued and outstanding shares of Common Stock equally. The Reverse Split also affected our
outstanding stock options, warrants and other exercisable or convertible securities and resulted in the shares underlying such instruments
being reduced and the exercise price being increased proportionately. No fractional shares were issued as a result of the Reverse Split.
Any fractional shares that would have otherwise resulted from the Reverse Split was paid in cash, at an amount equal to the resulting
fractional interest in one share of the Common Stock to which the stockholder would otherwise be entitled, multiplied by the closing
trading price of our Common Stock on May 2, 2024. Except as indicated otherwise herein, the calculations based on outstanding Common
Stock amounts after May 2, 2024 reflect the Reverse Split. Except where indicated otherwise therein, the documents incorporated by reference
herein do not reflect the Reverse Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><U>Nasdaq Continued Listing Rule Compliance</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 8, 2025, Safe &amp; Green Holdings
Corp. (the &ldquo;Company&rdquo;) received a decision letter from the Nasdaq Hearings Panel (the &ldquo;Panel&rdquo;) granting the Company&rsquo;s
request for continued listing on the Nasdaq Capital Market. The decision is conditioned on the Company maintaining full compliance with
all continued listing requirements of the Nasdaq Capital Market by August 28, 2025. On or before August 28, 2025, the Company must effect
a Reverse Stock Split and demonstrate compliance with Nasdaq Listing Rule 5550(a)(2) by achieving a closing bid price of $1.00 or more
per share for at least ten (10) consecutive business days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On or before July 18, 205, the Company must
publicly disclose that it has restructured the terms of its April 2025 offering to eliminate the Class B warrants and provide Nasdaq
with confirmation that no shares underlying the Class B warrants were issued. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>2025 Reverse Stock Split</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the above, the Company&rsquo;s
shareholders approved a Reverse Stock Split at a ratio of 1:64 on August 25, 2025, and affected the Reverse Stock Split on September
8, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Panel&rsquo;s decision follows the Company&rsquo;s
hearing before the Panel on June 17, 2025, during which the Company presented a plan to regain compliance, including its intention to
implement a Reverse Stock Split and restructure certain previously issued warrants to mitigate dilution concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Exchange Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On July 17, 2025, the Company entered into
an Exchange Agreement (the &ldquo;<U>Exchange Agreement</U>&rdquo;) by and among the Company and the Investors. Pursuant to the Exchange
Agreement, the parties intended to effect a voluntary security exchange transaction (the &ldquo;<U>Transaction</U>&rdquo;) whereby the
Investors will exchange the Series A and Series B Warrants previously purchased in the April 14, 2025 private placement (the &ldquo;April
2025 Private Placement&rdquo;) for an aggregate of 60,000 shares of Series B Preferred Stock (the &ldquo;<U>Exchange Shares</U>&rdquo;),
with the New Series B Convertible Preferred Stock&rsquo;s rights and preferences being set forth on that certain certificate of designation
(the &ldquo;<U>Certificate of Designation</U>&rdquo;) of the Company, filed with the State of Delaware on July 17, 2025, in substantially
in the form set forth as Exhibit 3.1 on the Company&rsquo;s current report on Form 8-K, filed on July 18, 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement contains other customary
provisions including representations and warranties for the Company and the Investors, governing law, and notice. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></DIV>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the above, the Company has
planned on Annual Meeting on August 25, 2025, and plans to conduct a Reverse Stock Split at a range of one-for-ten (1-for-10) to a maximum
of a one-for-one hundred (1-for-100) with the exact ratio to be determined by our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On June 11, 2025, Safe
&amp; Green Holdings Corp. (the &ldquo;Company&rdquo;) was notified by the Listing Qualifications Department of The Nasdaq Stock Market
LLC (&ldquo;Nasdaq&rdquo;) that, based upon the Company&rsquo;s continued non-compliance with the minimum $1.00 bid price requirement
set forth in Nasdaq Listing Rule 5550(a)(2) (the &ldquo;Rule&rdquo;) as of June 10, 2025, the deficiency could serve as an additional
basis for the delisting of the Company&rsquo;s securities from Nasdaq. The Company plans to present its plan to regain compliance with
the Rule at its upcoming hearing before the Nasdaq Hearings Panel. The notice no immediate effect on the listing or trading of the Company&rsquo;s
common stock and the Company&rsquo;s common stock will continue to trade under symbol &ldquo;SGBX&rdquo; at least pending the ultimate
conclusion of the hearing process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously disclosed, on December 12, 2024,
Nasdaq notified the Company that the bid price of its listed securities had closed at less than $1.00 per share over the previous 30 consecutive
business days and, as a result, the Company did not comply with the Rule. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company
was provided 180 calendar days, or until June 10, 2025, to regain compliance with the Rule. The Company was not eligible for a second
grace period to regain compliance with the Rule and, accordingly, the Staff issued the additional delist determination dated June 11,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> On May 13, 2025,
Safe &amp; Green Holdings Corp. (the &ldquo;Company&rdquo;) received a notification letter from the Listing Qualifications Department
of The Nasdaq Stock Market LLC (&ldquo;Nasdaq&rdquo;), stating that based on its review of the Company&rsquo;s public filings with the
Securities and Exchange Commission (the &ldquo;SEC&rdquo;), its staff has determined to delist the Company&rsquo;s securities pursuant
to its discretionary authority under Listing Rule 5101. Specifically, as set forth in the letter, Nasdaq&rsquo;s staff determined that
the Company&rsquo;s issuance of securities pursuant to the securities purchase agreement dated April 14, 2025, particularly the Series
B warrants exercisable on an alternate cashless basis as described in the Company&rsquo;s prior SEC filings, raises public interest concerns
because the issuance resulted in substantial dilution for its shareholders. Accordingly, as set forth in the letter, this matter serves
as an additional basis for delisting the Company&rsquo;s securities from Nasdaq. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> The letter serves
as a formal notification that the Nasdaq Hearings Panel (the &ldquo;Panel&rdquo;) will consider this matter in rendering a determination
regarding the Company&rsquo;s continued listing on Nasdaq. Pursuant to Listing Rule 5810(d), the Company should present its views with
respect to this additional deficiency at its upcoming Panel hearing. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has submitted an appeal of this determination
and held a hearing with the Nasdaq Panel on June 17, 2025, and has submitted a compliance plan to the Panel in connection with same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 8, 2025, Safe &amp; Green Holdings
Corp. (the &ldquo;Company&rdquo;) received a decision letter from the Nasdaq Hearings Panel (the &ldquo;Panel&rdquo;) granting the Company&rsquo;s
request for continued listing on the Nasdaq Capital Market. The decision is conditioned on the Company maintaining full compliance with
all continued listing requirements of the Nasdaq Capital Market by August 28, 2025. On or before August 28, 2025, the Company must effect
a Reverse Stock Split and demonstrate compliance with Nasdaq Listing Rule 5550(a)(2) by achieving a closing bid price of $1.00 or more
per share for at least ten (10) consecutive business days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On or before July 18, 2025, the Company complied
with this requirement regarding the restructured terms of its April 2025 offering to eliminate the Class B warrants and provided Nasdaq
with confirmation that the Series A and B Warrants were exchanged for the Series B Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2024 Nasdaq Deficiencies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April&nbsp;19, 2024, we received a delinquency
letter from the Nasdaq Stock Market LLC (&ldquo;Nasdaq&rdquo;) notifying us that we were not in compliance with the continued listing
requirements set forth in Nasdaq Listing Rule 5250(c)(1) (&ldquo;Rule&nbsp;5250(c)(1)&rdquo;), which requires timely filing of periodic
reports with the SEC for continued listing. On May&nbsp;13, 2024, we received a letter (the &ldquo;May 13 Compliance Notice&rdquo;) from
Nasdaq notifying the Company that it was now in compliance with Rule&nbsp;5250(c)(1). Based on the May&nbsp;7, 2024 and May&nbsp;10, 2024
filings of the Company&rsquo;s Form&nbsp;10-K&nbsp;and Form&nbsp;10-K/A, respectively, for the year ended December&nbsp;31, 2023, Nasdaq
has determined that the Company has regained compliance with Rule&nbsp;5250(c)(1), and this matter is now closed according to the May
13 Compliance Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May&nbsp;10, 2024, we received a letter (the
&ldquo;Delisting Notice&rdquo;) from Nasdaq notifying the Company that Nasdaq previously notified the Company on November&nbsp;7, 2023
that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (&ldquo;Rule 5550(a)(2)&rdquo;), which requires a minimum
bid price of at least $1.00 per share for continued listing. On May&nbsp;16, 2024, the Company received a letter (the &ldquo;May 16 Compliance
Notice&rdquo;) from Nasdaq notifying the Company that it was now in compliance with Rule 5550(a)(2). Based on the Company&rsquo;s closing
bid price at or greater than $1.00 per share for 10 consecutive business days, from May&nbsp;2, 2024 to May&nbsp;15, 2024, Nasdaq has
determined that the Company has regained compliance with Rule 5550(a)(2), and this matter is now closed according to the May 16 Compliance
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May&nbsp;16, 2024, the Company received a
letter (the &ldquo;Deficiency Notice&rdquo;) from Nasdaq notifying the Company that it was not in compliance with Nasdaq Listing Rule
5550(b)(1) (&ldquo;Rule 5550(b)(1)&rdquo;) because the stockholders&rsquo; equity of the Company of ($6,334,859), as reported in the
Company&rsquo;s Annual Report on Form 10-K&nbsp;for the year ended December&nbsp;31, 2023, was below the minimum requirement of $2.5&nbsp;million.
As of May&nbsp;17, 2024, the Company does not have a market value of listed securities of $35&nbsp;million, or net income from continued
operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years, the
alternative quantitative standards for continued listing on Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The notification received has no immediate effect
on the Company&rsquo;s continued listing on Nasdaq, subject to the Company&rsquo;s compliance with the other continued listing requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In accordance with Nasdaq&rsquo;s Listing Rules,
the Company had 45 calendar days from the date of the Deficiency Notice, or no later than June&nbsp;30, 2024, to submit a plan to regain
compliance with Rule 5550(b)(1) (a &ldquo;Compliance Plan&rdquo;). The Company has submitted a Compliance Plan within 45 calendar days
of the date of the Deficiency Notice and will evaluate available options to regain compliance. The Company was granted up to 180 calendar
days from May&nbsp;16, 2024, to evidence compliance with Rule 5550(b)(1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On November 18, 2024, we received a letter from
Nasdaq notifying the Company that the Company did not meet the terms of the extension granted by Nasdaq for the Company to comply with
the minimum $2,500,000 stockholders&rsquo; equity requirement for continued listing set forth in Listing Rule 5550(b). As a result, unless
the Company requests an appeal of this determination by November 25, 2024, trading of the company&rsquo;s common stock will be suspended
at the opening of business on November 27, 2024, and the Company&rsquo;s securities will be removed from listing and registration on
The Nasdaq Stock Market. The Company filed the requisite appeal and was granted a hearing at a Nasdaq panel to present its plan to cure
to the deficiency, at which time the panel may grant up to 6 months&rsquo; time for the Company to reach the required minimum of $2,500,000
in stockholders&rsquo; equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On December 12, 2024, the Company received a
letter from Nasdaq notifying the Company that for the preceding 30 consecutive business days (October 30, 2024 through December 11, 2024),
the Company&rsquo;s common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2).
The Company has an initial compliance period of 180 calendar days, or until June 10, 2025, to regain compliance, which may be achieved
if the closing bid price of the Company&rsquo;s common stock is at or above $1.00 for a minimum of ten consecutive business days. If
the Company does not achieve compliance by June 10, 2025, the Company may be eligible for additional time to comply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Smaller Reporting Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are currently a &ldquo;smaller reporting company,&rdquo;
meaning that we are not an investment company, an asset-backed&nbsp;issuer, or a majority-owned&nbsp;subsidiary of a parent company that
is not a smaller reporting company, and have a public float of less than $250&nbsp;million or annual revenues of less than $100&nbsp;million
during the most recently completed fiscal year. As a result of being considered a &ldquo;smaller reporting company,&rdquo; we will be
entitled to certain exemptions regarding the disclosure that we are required to provide in our SEC filings. Specifically, &ldquo;smaller
reporting companies&rdquo; are able to provide simplified executive compensation disclosures in their filings; are exempt from the provisions
of Section&nbsp;404(b)&nbsp;of Sarbanes-Oxley&nbsp;requiring that independent registered public accounting firms provide an attestation
report on the effectiveness of internal control over financial reporting; and have certain other decreased disclosure obligations in
their SEC filings, including, among other things, only being required to provide two&nbsp;years of audited financial statements in annual
reports. Decreased disclosures in our SEC filings due to our status as a &ldquo;smaller reporting company&rdquo; may make it harder for
investors to analyze our results of operations and financial prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><A NAME="a_003"></A><B>The
Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus relates to the resale from
time to time by the selling stockholder (the &ldquo;Selling Stockholder&rdquo;) identified in this prospectus under the caption &ldquo;Selling
Stockholder&rdquo; of up to 937,500 (post-Reverse Stock Split)shares of our Common Stock, par value $0.01 (our &ldquo;Common Stock&rdquo;),
underlying the Series B Convertible Preferred Stock (the &ldquo;<U>Shares</U>&rdquo;), issuable upon conversion of 60,000 shares of our
Series B Convertible Preferred Stock, par value $0.01 (the &ldquo;<U>Series B Preferred Stock</U>&rdquo;) issued to the Selling Stockholders
pursuant to an <FONT STYLE="background-color: white">Exchange Agreement (the &ldquo;</FONT><U>Exchange Agreement</U><FONT STYLE="background-color: white">&rdquo;)
by and among the Company and the Investors. Pursuant to the Exchange Agreement, the parties effected a voluntary security exchange transaction
(the &ldquo;</FONT><U>Transaction</U><FONT STYLE="background-color: white">&rdquo;) whereby the Investors exchanged the Series A and
Series B Warrants previously purchased in the April 14, 2025 private placement (the &ldquo;April 2025 Private Placement&rdquo;) for an
aggregate of 60,000 shares of Series B Preferred Stock (the &ldquo;</FONT><U>Exchange Shares</U><FONT STYLE="background-color: white">&rdquo;),
with the New Series B Convertible Preferred Stock&rsquo;s rights and preferences being set forth on that certain certificate of designation
filed in our current report on Form 8-K filed with the SEC on July 18, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We did not receive any proceeds from the Exchange
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not receive any proceeds from the sale
of the Registrable Securities by the Selling Stockholder under this prospectus. We provide more information about how we plan to use the
proceeds in the section titled &ldquo;Use of Proceeds&rdquo; on page 15 of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shares were offered and sold by us pursuant
to the exemption provided by Section 3(a)(9) of the Securities Act and Regulation D promulgated thereunder. We are registering
the offer and resale of the Registrable Securities to satisfy the provisions of that certain registration rights agreement, dated July
17, 2025 (the &ldquo;Registration Rights Agreement&rdquo;), pursuant to which we agreed to register the resale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholder may sell its Shares underlying
the Series B Preferred Stock described in this prospectus in a number of different ways and at varying prices. We provide more information
about how the Selling Stockholder may sell its shares underlying the Series B Preferred Stock in the section titled &ldquo;Plan of Distribution&rdquo;
on page 18 of this prospectus. We will pay the expenses incurred in registering the securities covered by this prospectus, including legal
and accounting fees. To the extent the Selling Stockholder decides to sell any of its Shares underlying the Series B Preferred Stock,
we will not control or determine the price at which the shares are sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is listed on the Nasdaq Capital Market under the symbol
&ldquo;SGBX&rdquo;. On September 30, 2025, the last reported sale price of our Common Stock on the Nasdaq Capital Market was $7.18 per
share. We urge prospective purchasers of our Common Stock to obtain current information about the market prices of our Common Stock.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-size: 10pt; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities&nbsp;offered&nbsp;by&nbsp;the&nbsp;Selling&nbsp;Stockholder</FONT></TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 68%">937,500 shares of Common Stock underlying the Series B Preferred Stock (post-Reverse
    Stock Split).</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Common Stock to be outstanding after this offering,
    assuming conversion of the Series B Preferred Stock</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">4,687,500 shares (post-Reverse Stock Split and assuming full conversion of the Series B Preferred
    Stock).</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Terms of the Offering</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Selling Stockholder and any of its pledgees, assignees and successors-in-interest will determine when and how they sell the shares offered in this prospectus and may, from time to time, sell any or all of their shares covered hereby on The Nasdaq Capital Market or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. These sales may be at fixed or negotiated prices. See &ldquo;Plan of Distribution&rdquo; in this prospectus.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Use of Proceeds</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We did not receive any proceeds from the Exchange Agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">We will not receive any proceeds from the resale, if any, of the Registrable Securities by the Selling Stockholder. See &ldquo;Use of Proceeds.&rdquo;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Risk Factors</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Investment in our securities involves a high degree of risk and could result in a loss of your entire investment. See &ldquo;Risk Factors&rdquo; beginning on page 11 and the similarly entitled sections in the documents incorporated by reference into this prospectus.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Nasdaq Capital Market Symbol</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Our Common Stock is listed on the Nasdaq Capital Market under the symbol &ldquo;SGBX&rdquo;.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except
                                            as otherwise indicated herein, the number of shares of our Common Stock to be outstanding
                                            after this offering is based on 503,474 shares of Common Stock outstanding as of September
                                            30, 2025, plus the 937,500 Shares (post-Reverse Stock Split), assuming we issue the additional
                                            937,500shares of Common Stock (post-Reverse Stock Split) that are issuable pursuant to the
                                            conversion of the Series B Preferred Stock and excludes the following, which numbers have
                                            been adjusted for the Company&rsquo;s Reverse Stock Split, effective September 8, 2025:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify"><TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">28
                                            shares of Common Stock issuable upon the exercise of outstanding options at a weighted average
                                            exercise price of $199,748.80 per share;</P>
</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">97,809
                                            shares of Common Stock issuable upon the exercise of separate outstanding warrants at a weighted-average
                                            exercise price of $74.24 per share;</P>
</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">7,382 shares
                                            of Common Stock issuable upon vesting of outstanding restricted stock units under our equity
                                            incentive plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, all information in
this prospectus assumes no exercise of the outstanding options and warrants and no vesting of the restricted stock units described in
the bullets above. To the extent that options or warrants are exercised, restricted stock units vest, new awards are granted under our
equity incentive plan, or we issue additional shares of Common Stock or warrants in the future, there will be further dilution to investors
participating in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investing in our securities involves a high degree
of risk. Before investing in our securities, you should carefully consider the risks, uncertainties and assumptions contained in this
prospectus and discussed under the heading &ldquo;Risk Factors&rdquo; included in our most recently filed Form&nbsp;10-K, as revised
or supplemented by subsequent filings, which are on file with the SEC and are incorporated herein by reference, and which may be amended,
supplemented or superseded from time to time by other reports we file with the SEC in the future. Our business, financial condition,
results of operations and future growth prospects could be materially and adversely affected by any of these risks. In these circumstances,
the market price of our Common Stock could decline, and you may lose all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Investors who buy shares at different times
will likely pay different prices.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investors who purchase shares in this offering
at different times will likely pay different prices, and so may experience different levels of dilution and different outcomes in their
investment results. Similarly, the Selling Stockholder may sell such shares at different times and at different prices. Investors may
experience a decline in the value of the shares they purchase from the Selling Stockholder in this offering as a result of sales made
by us in future transactions to the Selling Stockholder at prices lower than the prices they paid. The Selling Stockholder will have
discretion to vary the timing, prices, and number of shares sold in this offering. Investors may experience a decline in the value of
their shares of our Common Stock. The trading price of our Common Stock has been volatile and subject to wide fluctuations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The issuance of Common Stock to the Selling
Stockholder upon conversion of the Series B Preferred Stock may cause substantial dilution to our existing stockholders and the sale of
such shares acquired by the Selling Stockholder could cause the price of our Common Stock to decline.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are registering for resale by the Selling
Stockholder of up to 937,500shares of our Common Stock (post-Reverse Stock Split), par value $0.01, underlying the Series B Convertible
Preferred Stock, issuable upon conversion of 60,000 shares of our Series B Convertible Preferred Stock. The number of shares of our Common
Stock ultimately offered for resale by the Selling Stockholder under this prospectus is dependent the number of Registrable Securities
issued. Depending on a variety of factors, including market liquidity of our Common Stock, the issuance of shares to the Selling Stockholder
may cause the trading price of our Common Stock to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our need for future financing may result
in the issuance of additional securities, which will cause investors to experience dilution.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cash requirements may vary from those now
planned depending upon numerous factors. We expect to require additional capital until our operations generate sufficient revenue to
cover our expenses. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations.
Our securities may be offered to other investors at a price lower than the price per share offered to current stockholders, or upon terms
which may be deemed more favorable than those offered to current stockholders. In addition, the issuance of securities in any future
financing may dilute an investor&rsquo;s equity ownership and have the effect of depressing the market price for our securities. Moreover,
we may issue derivative securities, including options, restricted stock units or warrants, from time to time, to procure qualified personnel
or for other business reasons. The issuance of any such derivative securities, which is at the discretion of our board of directors,
may further dilute the equity ownership of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We have additional securities available
for issuance, which, if issued, could adversely affect the rights of the holders of our Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Amended and Restated Certificate of Incorporation,
as amended, authorizes the issuance of 75,000,000&nbsp;shares of our Common Stock and 5,405,010&nbsp;shares of preferred stock. In certain
circumstances, the Common Stock, as well as the awards available for issuance under our equity incentive plan, can be issued by our board
of directors, without stockholder approval. Any future issuances of such stock, including pursuant to outstanding equity awards, would
further dilute the percentage ownership of us held by holders of Common Stock. In addition, the issuance of certain securities, may be
used as an &ldquo;anti-takeover&rdquo; device without further action on the part of our stockholders, and may adversely affect the holders
of the Common Stock.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Future sales of our Common Stock could
cause the market price for our Common Stock to decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We cannot predict the effect, if any, that market
sales of shares of our Common Stock or the availability of shares of our Common Stock for sale will have on the market price of our Common
Stock prevailing from time to time. Sales of substantial amounts of shares of our Common stock in the public market, or the perception
that those sales will occur, could cause the market price of our Common Stock to decline or be depressed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of Common Stock issued in connection
with this offering will be freely tradeable without restriction or further registration under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Because we will not declare cash dividends
on our Common Stock in the foreseeable future, stockholders must rely on appreciation of the value of our Common Stock for any return
on their investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have never declared or paid cash dividends
on our Common Stock. We currently anticipate that we will retain future earnings for the development, operation and expansion of our
business and will not declare or pay any cash dividends in the foreseeable future. As a result, only appreciation of the price of our
Common Stock, if any, will provide a return to investors in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_005"></A><B>CAUTIONARY NOTE REGARDING
FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus and the documents incorporated
by reference into this prospectus include forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act&nbsp;of&nbsp;1933
and Section&nbsp;21E of the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as amended, that relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity,
performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or
implied by these forward-looking statements. Words such as, but not limited to, &ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo; &ldquo;believe,&rdquo;
&ldquo;contemplate,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;design,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo;
&ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo; &ldquo;poise,&rdquo; &ldquo;project,&rdquo;
&ldquo;potential,&rdquo; &ldquo;suggest,&rdquo; &ldquo;should,&rdquo; &ldquo;strategy,&rdquo; &ldquo;target,&rdquo; &ldquo;will,&rdquo;
&ldquo;would,&rdquo; and similar expressions or phrases, or the negative of those expressions or phrases, are intended to identify forward-looking
statements, although not all forward-looking statements contain these identifying words. Although we believe that we have a reasonable
basis for each forward-looking statement contained in this prospectus and incorporated by reference into this prospectus, we caution
you that these statements are based on our projections of the future that are subject to known and unknown risks and uncertainties and
other factors that may cause our actual results, level of activity, performance or achievements expressed or implied by these forward-looking
statements, to differ. The section in this prospectus&nbsp;entitled &ldquo;<I>Risk Factors</I>&rdquo; and the sections in our periodic
reports, including our most recent Form&nbsp;10-K entitled &ldquo;Business,&rdquo; and in the Form&nbsp;10-K and the subsequent Forms
10-Q entitled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations,&rdquo; as well as other
sections in this prospectus and the documents or reports incorporated by reference into this prospectus, discuss some of the factors
that could contribute to these differences. These forward-looking statements include, among other things, statements about:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Risks Relating to our Financial Position and
Capital Requirements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We could
                                            experience a shortfall in cash over the next twelve&nbsp;months.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our independent
                                            registered public accounting firm has expressed doubt about our ability to continue as a
                                            going concern.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We have
                                            incurred net losses in prior periods and there can be no assurance that we will generate
                                            income in the future.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">To date
                                            we have not generated revenue from SG Medical Co or SG Environmental Services.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We will
                                            need to raise additional capital to fund our existing operations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We must
                                            timely register the shares issuable under the Debenture and the Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We may
                                            not have an adequate number of shares of common stock authorized to complete future equity
                                            transactions.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Risks Relating to our Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our ability
                                            to meet our workforce needs is crucial to our results of operations and future sales and
                                            profitability.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We have
                                            a fixed cost base that will affect our profitability if our sales decrease.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A material
                                            disruption of our suppliers or SG Echo&rsquo;s facilities could prevent us from meeting customer
                                            demand.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A natural
                                            disaster, the effects of climate change, or other disruptions at our SG&nbsp;Echo facility
                                            could adversely affect us.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The requirements
                                            of being a public company may strain our resources and divert management&rsquo;s attention.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We are
                                            dependent on the services of key personnel, a few customers and vendors.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We currently
                                            are, and may in the future be, subject to legal proceedings or investigations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The loss
                                            customers or vendors could have a material adverse effect on us.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Risks Relating to our Business and Industry</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Changes
                                            in general economic conditions and geopolitical and other conditions may adversely impact
                                            our business.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Limited
                                            availability or increases in costs of transportation could adversely affect our business
                                            and operations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Expansion
                                            of our operations may strain resources.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our clients
                                            may adjust, cancel or suspend the contracts in our backlog.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our liability
                                            for estimated warranties may be inadequate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We can
                                            be adversely affected by failures of persons who act on our behalf to comply with applicable
                                            regulations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The&nbsp;cyclical
                                            and seasonal nature of the construction industry causes our revenues and operating results
                                            to fluctuate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our&nbsp;business
                                            depends on the construction industry and general business, financial market and economic
                                            conditions.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our business
                                            relies on private investment and a slower than expected economy may adversely affect our
                                            results.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A material
                                            disruption at&nbsp;one&nbsp;of our suppliers&rsquo; facilities could negatively affect our
                                            overall financial results.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We are
                                            subject to risks regarding environmental, health and safety laws and regulations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our business
                                            may be subject to economic and political risks of vendors obtaining supplies from foreign
                                            countries.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our operating
                                            results will be subject to fluctuations and are inherently unpredictable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We are
                                            subject to cybersecurity&nbsp;risks.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We could
                                            suffer adverse tax and other financial consequences if we are unable to utilize our net operating
                                            loss&nbsp;carryforwards.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Risks Relating to our Common Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B><I>We have failed, and may continue to
fail, to meet the listing standards of Nasdaq, and as a result our common stock may become delisted, which could have a material adverse
effect on the liquidity of our common stock.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> If we fail to continue to satisfy the continued
listing requirements of Nasdaq, such as the corporate governance or public float requirements, or the minimum closing bid price requirement,
Nasdaq will take steps to de-list our common stock. As a result of several factors, including but not limited to our financial performance,
market sentiment about our industry, volatility in the financial markets generally due to the tightening of monetary policy by the Board
of Governors of the United States Federal Reserve Bank (the &ldquo;Federal Reserve&rdquo;) and other geopolitical events, events such
as the ongoing wars around the world, the per share price of our common stock has declined below the minimum bid price threshold required
for continued listing. Such a de-listing would likely have a negative effect on the price of our common stock and would impair your ability
to sell or purchase our common stock when you wish to do so, as well as adversely affect our ability to issue additional securities and
obtain additional financing in the future. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Failure
                                            to meet the continued listing requirements of the&nbsp;Nasdaq&nbsp;Capital Market could result
                                            in a delisting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our stock
                                            price has been subject to fluctuations in the past, has recently been volatile and our stock
                                            is thinly traded.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The requirements
                                            of being a public company may strain our resources.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Sales of
                                            shares of our common stock, could cause the price of our common stock to decline and result
                                            in dilution.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Certain
                                            provisions of Delaware law could discourage, delay or prevent a merger or acquisition at
                                            a premium price.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">We have
                                            availed ourselves of reduced disclosure requirements, which may make our common stock less
                                            attractive.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not actually achieve the plans, intentions
or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements.
Forward-looking statements should be regarded solely as our current plans, estimates and beliefs. We have included important factors
in the cautionary statements included in this document, particularly in the section entitled &ldquo;Risk Factors&rdquo; beginning on
page 11 of this prospectus that we believe could cause actual results or events to differ materially from the forward-looking statements
that we make. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is
not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which
any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements
we may make. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.
All forward-looking statements are qualified in their entirety by this cautionary statement. Our forward-looking statements do not reflect
the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make. You should read this
prospectus and the documents that we have filed as exhibits to this prospectus and incorporated by reference herein completely and with
the understanding that our actual future results may be materially different from the plans, intentions and expectations disclosed in
the forward-looking statements we make. The forward-looking statements contained in this prospectus are made as of the date of this prospectus
and we do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or
otherwise, except as required by applicable law.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_006"></A><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">We will
not receive any of the proceeds from the sale of the Registrable Securities by the Selling Stockholder. We will bear all fees and expenses
incident to our obligation to register the shares of Common Stock. Brokerage fees, commissions and similar expenses, if any, attributable
to the sale of shares offered hereby will be borne by the applicable selling stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The prices at which the Registrable Securities
may actually be sold will be determined by the prevailing public market price for shares of our Common Stock, by negotiations between
the Selling Stockholder and buyers of our Common Stock in private transactions or as otherwise described in &ldquo;Plan of Distribution.&rdquo;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_007"></A><B>SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the ownership of our
Common Stock beneficially owned by our current directors, named executive officers, our directors and current executive officers as a
group and our 5% stockholders as of September 30, 2025 and as adjusted to reflect the sale of the securities offered in this offering
(assuming the issuance of 937,500 shares of Common Stock underlying the Series B Preferred Stock (post-Reverse Stock Split) being registered
in this offering by (i) each current director, (ii) each named executive officer, (iii) each person who we know to be the beneficial owner
of more than 5% of our Common Stock, and (iv) all current directors and executive officers as a group. The persons named in the table
have sole voting and investment power with respect to all shares of our Common Stock shown as beneficially owned by them. Percentage ownership
prior to this offering is based on 763,434 shares of our Common Stock outstanding as of September 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, the address of each
beneficial owner listed in the table below is c/o Safe and Green Development Corporation, 990 Biscayne Boulevard, #501, Office 12, Miami,
Florida 33132.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have determined beneficial ownership in accordance
with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting
power or investment power with respect to those securities. In addition, the rules include shares of Common Stock issuable pursuant to
the exercise of profits interest units, warrants or other rights that are either immediately exercisable or exercisable on or before September
30, 2025, which is approximately 60 days after the date of this prospectus. These shares are deemed to be outstanding and beneficially
owned by the person holding those options or warrants for the purpose of computing the percentage ownership of that person, but they are
not treated as outstanding for the purpose of computing the percentage ownership of any other person. Unless otherwise indicated, the
persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned
by them, subject to applicable community property laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares of<BR>
 Common<BR>
 Stock<BR>
 Beneficially<BR>
 Owned</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Percentage&nbsp;of <BR>
Common&nbsp;Stock<BR>
 Beneficially<BR>
 Owned Prior<BR>
 to this<BR>
 Offering</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Paul M. Galvin, Former Chairman and Former Chief Executive Officer</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 10pt">3,395</FONT></TD><TD STYLE="padding-bottom: 4pt; width: 1%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Michael McLaren, Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">109,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14.31</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jim Pendergast, Chief Operating Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Patricia Kaelin, Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">185</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">William Rogers, Former Chief Operating Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jill Anderson, Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">418</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shafron Hawkins, Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">435</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Thomas Meharey, Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Christopher Melton, Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">444</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><SUP>(2)</SUP><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">David Villarreal, Former Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">580</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All current executive officers and directors as a group (6 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">115,246</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.10</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">5% Stockholders other than executive officers and directors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Less than 1% ownership interest.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Includes 669 shares
                                            of Common Stock held directly by Mr. Galvin and 1 shares held by TAG Partners, LLC (&ldquo;TAG&rdquo;),
                                            an investment partnership formed for the purpose of investing in the Company. Mr. Galvin
                                            is a managing member of, and has a controlling interest in, TAG and may be deemed to beneficially
                                            own the share of Common Stock held by TAG, over which he has shared voting and dispositive
                                            power. Mr. Galvin disclaims beneficial ownership of the shares of Common Stock held by TAG
                                            except to the extent of his pecuniary interest therein. Also includes 19 options to purchase
                                            our Common Stock presently exercisable.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Includes 1 shares
                                            of Common Stock held in Mr. Melton&rsquo;s retirement account, which Mr. Melton indirectly
                                            owns, and 69 shares of Common Stock held directly by Mr. Melton.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_008"></A><B>SELLING STOCKHOLDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of Common Stock underlying the Series
B Preferred Stock being offered by the Selling Stockholder are the Registrable Securities, consisting of the Shares. For additional information
regarding the issuance of these securities, see &ldquo;Prospectus Summary &mdash; The Offering&rdquo; on page 9 of this prospectus. We
are registering the Registrable Securities in order to permit the Selling Stockholder to offer the Shares for resale from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information
with respect to the Selling Stockholder, including (i) the number of shares of our Common Stock beneficially owned by the Selling Stockholder
prior to this offering, (ii) the number of shares of Common being offered by the Selling Stockholder pursuant to this prospectus, and
(iii) the Selling Stockholder&rsquo;s beneficial ownership after completion of this offering assuming the sale of all of the shares of
Common Stock covered by this prospectus. The registration of the Registrable Securities does not necessarily mean that the Selling Stockholder
will sell all or any of the Registrable Securities, but the number of shares and percentages set forth in the final two columns below
assume that all Registrable Securities are sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table is based on information supplied
to us by the Selling Stockholder, with beneficial ownership and percentage ownership determined in accordance with the rules and regulations
of the SEC and includes voting or investment power with respect to shares of stock. This information does not necessarily indicate beneficial
ownership for any other purpose. In computing the number of shares beneficially owned by a Selling Stockholder and the percentage ownership
of that Selling Stockholder, shares of Common Stock subject to warrants held by that Selling Stockholder that are exercisable within
60 days after September 30, 2025, are deemed outstanding. The percentage of beneficial ownership after this offering is based on 503,474
shares of Common Stock outstanding assuming the issuance of all of the 937,500shares of Common Stock (post-Reverse Stock Split) being
registered in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have assumed that all shares of Common Stock
reflected in the table as being offered in the offering covered by this prospectus will be sold from time to time in this offering. We
cannot provide an estimate as to the number of shares of Common Stock that will be held by the Selling Stockholder upon termination of
the offering covered by this prospectus because the Selling Stockholder may offer some, all or none of the shares of Common Stock being
offered in the offering. Information about the Selling Stockholder may change over time. Any changed information will be set forth in
an amendment to the registration statement or supplement to this prospectus, to the extent required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Number of<BR> Shares of<BR> Common
    Stock<BR> Beneficially<BR> Owned<BR> Prior to<BR> this</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maximum<BR>
    Number of<BR> Shares of<BR> Common Stock<BR> to be Offered<BR> for Resale<BR> in this<BR> Offering<SUP>(2)</SUP>&nbsp;</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Shares
    of<BR> Common Stock<BR> Beneficially<BR> Owned<BR> Immediately<BR> Following this<BR> Offering<SUP>(1)</SUP>&nbsp;</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Offering<SUP>(1)</SUP>&nbsp;</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Great Point Capital LLC(3)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">234,375</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">234,375</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">East West Capital, LLC(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&mdash;</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Robert Forster (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Sabby Volatility Warrant Master Fund, Ltd.(6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Number and Percentage
                                            are based on 503,474 shares of Common Stock outstanding as of September 8, 2025, assuming
                                            the resale of all Common Stock underlying the Series B Preferred Stock covered by this prospectus
                                            and giving effect to the beneficial ownership blockers held by the Selling Shareholder, and
                                            are adjusted to account for the Company&rsquo;s 2025 Reverse Stock Split.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Consists of 234,375
                                            shares of common stock underlying the Series B Preferred Stock.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Consists of 234,375
                                            Common Shares underlying the Series B Preferred Stock. Dan Dimiero is the natural control
                                            person of Great Point Capital, LLC, with an address of 12301 Research Blvd., Building 4-270
                                            Austin, TX 78759.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">Consists of 234,375
                                            Common Shares underlying the Series B Preferred Stock. John Fife is the natural control person
                                            of East West Capital, LLC, with an address of 2005 East 2700 South STE 200, Salt Lake City,
                                            UT, 84109.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">Consists of 234,375
                                            Common Shares underlying the Series B Preferred Stock. <FONT STYLE="background-color: white">The
                                            address for Robert Forster is 54 Deepdale Drive, Great Neck, NY 11021.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">The 234,375 Common
                                            Shares underlying the Series B Preferred Stock and other securities are held by Sabby Volatility
                                            Warrant Master Fund, Ltd. (&ldquo;Sabby&rdquo;). Sabby Management, LLC, the investment manager
                                            to Sabby, has discretionary authority to vote and dispose of the shares held by Sabby and
                                            may be deemed to be the beneficial owner of these shares. Additionally, this does not include
                                            68,782 Common Shares issuable upon exercise of Pre-funded Warrants. Hal Mintz (&ldquo;Mr.
                                            Mintz&rdquo;), in his capacity as manager of Sabby Management, LLC, may also be deemed to
                                            have investment discretion and voting power over the shares held by Sabby. Sabby Management,
                                            LLC and Mr. Mintz each disclaim any beneficial ownership of these shares.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Relationship with Selling Stockholder</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To our knowledge, the Selling Stockholder did
not have any position, office, or other material relationship with us or any of our affiliates within the past three&nbsp;years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_009"></A><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholder and any of its pledgees,
assignees and successors-in-interest may, from time to time, sell any or all of its securities covered hereby on The Nasdaq Capital Market
or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may
be at fixed or negotiated prices. The Selling Stockholder may use any one or more of the following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">block trades
                                            in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its account;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exchange
                                            distribution in accordance with the rules of the applicable exchange;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">privately
                                            negotiated transactions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">settlement
                                            of short sales;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">in transactions
                                            through broker-dealers that agree with the Selling Stockholder to sell a specified number
                                            of such securities at a stipulated price per security;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">a combination
                                            of any such methods of sale; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any other
                                            method permitted pursuant to applicable law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholder may also sell securities
under Rule&nbsp;144 or any other exemption from registration under the Securities Act, if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broker-dealers engaged by the Selling Stockholder
may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholder
(or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except
as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission
in compliance with FINRA Rule&nbsp;2440; and in the case of a principal transaction, a markup or markdown in compliance with FINRA IM-2440.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the sale of the securities
or interests therein, the Selling Stockholder may enter into hedging transactions with broker-dealers or other financial institutions,
which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholder
may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers
that in turn may sell these securities. The Selling Stockholder may also enter into option or other transactions with broker-dealers
or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other
financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may
resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholder and any broker-dealers
or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities
Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale
of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. The Selling Stockholder
has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person
to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are required to pay certain fees and expenses
incurred by us incident to the registration of the securities. We have agreed to indemnify the Selling Stockholder against certain losses,
claims, damages and liabilities, including liabilities under the Securities Act.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We agreed to keep this prospectus effective until
the Selling Stockholder does not own any shares of Common Stock underlying the Series B Preferred Stock. In addition, in certain states,
the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or
an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to applicable rules and regulations
under the Exchange&nbsp;Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the Common Stock for the applicable restricted period, as defined in Regulation&nbsp;M, prior to the
commencement of the distribution. In addition, the Selling Stockholder will be subject to applicable provisions of the Exchange&nbsp;Act
and the rules and regulations thereunder, including Regulation&nbsp;M, which may limit the timing of purchases and sales of the Common
Stock by the Selling Stockholder or any other person. We will make copies of this prospectus available to the Selling Stockholder and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule&nbsp;172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>DESCRIPTION OF OUR SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The following description of our capital stock
and the provisions of our amended and restated certificate of incorporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;)
and our amended and restated bylaws (the &ldquo;Bylaws&rdquo;) are summaries and are qualified by reference to the certificate of incorporation
and the bylaws. We have filed copies of these documents with the SEC as exhibits to our registration statement of which this prospectus
forms a part.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Description of Common Stock</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Authorized Shares of Common Stock.&nbsp;&nbsp;</I>We
currently have authorized 75,000,000&nbsp;shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Voting.&nbsp;&nbsp;</I>Holders of our Common
Stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders, including the election
of directors, and do not have cumulative voting rights. Our directors are elected by a plurality of the votes cast by the stockholders
entitled to vote at our annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dividends.&nbsp;&nbsp;</I>Subject to the prior
rights of any class or series of preferred stock which may from time to time be outstanding, if any, holders of our Common Stock are
entitled to receive dividends ratably when, as and if declared by our Board of Directors, out of funds legally available for that purpose.
We have not paid any dividends on our Common Stock and none are contemplated in the foreseeable future. We anticipate that all earnings
that may be generated from our operations will be used to finance our growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Liquidation.&nbsp;&nbsp;</I>Upon our liquidation,
dissolution or winding up, holders of the Common Stock are entitled to share ratably in all assets remaining after payment of liabilities
and payment of accrued dividends and liquidation preferences on the preferred stock, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Rights and Preferences.&nbsp;&nbsp;</I>The
holders of our Common Stock have no preemptive, subscription or redemption rights pertaining to our Common Stock and have no rights to
convert their Common Stock into any other securities. The absence of preemptive rights could result in a dilution of the interest of
the existing stockholders should additional shares of our Common Stock be issued. In addition, the rights of holders of our Common Stock
are subject to, and may be adversely affected by, the rights of holders of shares of any series of preferred stock that we may designate
and issue in the future. See &ldquo;Risk Factors&rdquo; section in our most recent Form&nbsp;10-K for a further description of risks
related to our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fully Paid and Nonassessable.&nbsp;&nbsp;</I>All
of our issued and outstanding shares of Common Stock are fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Description of the Series B Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Series B Preferred
Stock Certificate of Designation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On July 17, 2025, the
Company filed a Certificate of Designation (the &ldquo;<U>Certificate of Designation</U>&rdquo;) with the Delaware Secretary of State
designating, 60,000 shares as Series B Convertible Preferred Stock (the &ldquo;<U>Series B Preferred Stock</U>&rdquo;), each with a stated
value of $1,000 per share (the &ldquo;<U>Stated Value</U>&rdquo;). The Certificate of Designation sets forth the rights, preferences and
limitations of the shares of Series B Preferred Stock. Terms not otherwise defined in this item shall have the meanings given in the Certificate
of Designation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following is a summary
of the terms of the Series B Preferred Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I><U>Dividends</U>.&nbsp;</I>At
all times following the issuance of the Series B Preferred Stock, while shares of Series B Preferred Stock are issued and outstanding,
holders of Series B Preferred Stock shall be entitled to receive, and the Company shall pay, dividends on shares of Series B Preferred
Stock equal (on an as-if-converted-to-Common-Stock basis and without regard to any limitations on conversion set forth herein or otherwise)
to and in the same form as dividends (which shall be made in accordance with the terms of the Certificate of Designation) actually paid
on shares of the Company&rsquo;s Common Stock (the &ldquo;<U>Common Stock</U>&rdquo;) when, as and if such dividends (which shall be made
in accordance with the terms of the Certificate of Designation) are paid on shares of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I><U>Voting Rights</U></I>.
Subject to certain limitations described in the Certificate of Designation, the Series B Preferred Stock is voting stock. The issuance
of preferred stock has limited voting power, such that the preferred stock would vote as if converted at the &ldquo;Nasdaq Minimum Price&rdquo;
as defined in Listing Rule 5635(d)(1), on the date of issuance. Notwithstanding the foregoing, the holders of the Series B Preferred Stock
shall not be permitted to vote in excess of 19.99% until shareholder approval for the Series B Preferred Stock is obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I><U>Liquidation</U></I>.
Upon any Liquidation (as defined in the Certificate of Designation), the assets of the Company available for distribution to its stockholders
shall be distributed among the holders of the shares of the Company&rsquo;s Series A Convertible Preferred Stock, Series B Preferred Stock
and Common Stock, pro rata based on the number of shares held by each such holder, treating for this purpose all shares of Series B Preferred
Stock as if they had been converted to Common Stock pursuant to the terms of the Certificate of Designation immediately prior to such
Liquidation, without regard to any limitations on conversion set forth in the Certificate of Designation or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> <I><U>Conversion</U>.&nbsp;</I>Subject
to the limitations set forth in the Certificate of Designation, at the option of the holder, each share of Series B Preferred Stock shall
be convertible into a number shares of Common Stock obtained by dividing the Stated Value of each such share of Series B Preferred Stock
by the Floor Price of $0.20 (the &ldquo;Floor <U>Price</U>&rdquo;). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foregoing summary
of the terms of the Series B Preferred Stock is qualified in its entirety by reference to the text of the Certificate of Designation,
which is filed on the Company&rsquo;s current report on Form 8-K, on July 18, 2025, and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Resale/Registration Rights. </I>We have filed
this registration statement with the SEC that includes this prospectus to register for resale under the Securities Act, the Registrable
Securities, consisting of the Shares underlying the Series B Preferred Stock, to satisfy our obligations in connection with the July 17,
2025, Exchange Agreement. We are required to use commercially reasonable efforts to cause such registration to become effective by August
18, 2025, within 22 days of the closing of the July 17, 2025 transaction (or September 10, 2025, in the event of a full review by the
SEC) for the Registrable Securities, and to keep such registration statement effective at all times until the Selling Stockholder does
not own any Registrable Securities.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Nasdaq Continued Listing Rule Compliance</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 8, 2025, Safe &amp; Green Holdings
Corp. (the &ldquo;Company&rdquo;) received a decision letter from the Nasdaq Hearings Panel (the &ldquo;Panel&rdquo;) granting the Company&rsquo;s
request for continued listing on the Nasdaq Capital Market. The decision is conditioned on the Company maintaining full compliance with
all continued listing requirements of the Nasdaq Capital Market by August 28, 2025. On or before August 28, 2025, the Company must effect
a Reverse Stock Split and demonstrate compliance with Nasdaq Listing Rule 5550(a)(2) by achieving a closing bid price of $1.00 or more
per share for at least ten (10) consecutive business days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On or before July 18, 205, the Company must publicly
disclose that it has restructured the terms of its April 2025 offering to eliminate the Class B warrants and provide Nasdaq with confirmation
that no shares underlying the Class B warrants were issued.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Panel&rsquo;s decision follows the Company&rsquo;s
hearing before the Panel on June 17, 2025, during which the Company presented a plan to regain compliance, including its intention to
implement a Reverse Stock Split and restructure certain previously issued warrants to mitigate dilution concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2025 Reverse Stock
Split</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">In connection with the above, the Company&rsquo;s
shareholders approved a Reverse Stock Split at a ratio of 1:64 on August 25, 2025, and affected the Reverse Stock Split on September
8, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Anti-Takeover Effects of Delaware Law and
Our Certificate of Incorporation and Bylaws</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions of Delaware law, our Certificate
of Incorporation and our Bylaws contain provisions that could have the effect of delaying, deferring or discouraging another party from
acquiring control of us. These provisions, which are summarized below, are expected to discourage certain types of coercive takeover
practices and inadequate takeover bids. These provisions are also designed, in part, to encourage persons seeking to acquire control
of us to first negotiate with our Board of Directors. We believe that the benefits of increased protection of our potential ability to
negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging such proposals, including proposals that
are priced above the then-current market value of our common stock, because, among other reasons, such negotiation could result in an
improvement of the terms of such proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Certificate of Incorporation and Bylaws</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions set forth in our Certificate
of Incorporation, our Bylaws and in Delaware law, which are summarized below, may be deemed to have an anti-takeover effect and may delay,
deter or prevent a tender offer or takeover attempt that a stockholder might consider to be in its best interests, including attempts
that might result in a premium being paid over the market price for the shares held by stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Proposals of business and nominations.&nbsp;&nbsp;</I>Our
Bylaws generally regulate proposals of business and nominations for election of directors by stockholders. In general, Section&nbsp;3.16
requires stockholders intending to submit proposals or nominations at a stockholders meeting to provide the Company with advance notice
thereof, including information regarding the stockholder proposing the business or nomination as well as information regarding the proposed
business or nominee. Section&nbsp;3.16 provides a time period during which business or nominations must be provided to the Company that
will create a predictable window for the submission of such notices, eliminating the risk that the Company finds a meeting will be contested
after printing its proxy materials for an uncontested election and providing the Company with a reasonable opportunity to respond to
nominations and proposals by stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Blank Check Preferred Stock.&nbsp;&nbsp;</I>Our
Board of Directors has the right to issue preferred stock in one or more series and to determine the designations, rights, preferences
of such preferred stock without stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Board Vacancies.&nbsp;&nbsp;</I>Our
Bylaws generally provide that only the board of directors (and not the stockholders) may fill vacancies and newly created directorships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While the foregoing provisions of our Certificate
of Incorporation, Bylaws and Delaware law may have an anti-takeover effect, these provisions are intended to enhance the likelihood of
continuity and stability in the composition of the Board of Directors and in the policies formulated by the Board of Directors and to
discourage certain types of transactions that may involve an actual or threatened change of control. In that regard, these provisions
are designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain
tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers
for our shares and, as a consequence, they also may inhibit fluctuations in the market price of our common stock that could result from
actual or rumored takeover attempts. Such provisions also may have the effect of preventing changes in our management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Series B Preferred Stock Certificate of
Designation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On July 17, 2025,
the Company filed a Certificate of Designation (the &ldquo;<U>Certificate of Designation</U>&rdquo;) with the Delaware Secretary of State
designating, 60,000 shares as Series B Convertible Preferred Stock (the &ldquo;<U>Series B Preferred Stock</U>&rdquo;), each with a stated
value of $1,000 per share (the &ldquo;<U>Stated Value</U>&rdquo;). The amount of Series B Preferred Stock is multiplied by the Stated
Value, which equals 937,500 (post-Reverse Stock Split), and then divided by the Floor price of $0.20, which equals 4,687,500 shares (post-Reverse
Stock Split), in which we are registering 937,500 shares herein (post-Reverse Stock Split). The Certificate of Designation sets forth
the rights, preferences and limitations of the shares of Series B Preferred Stock. Terms not otherwise defined in this item shall have
the meanings given in the Certificate of Designation.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following is a summary
of the terms of the Series B Preferred Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I><U>Dividends</U>.&nbsp;</I>At
all times following the issuance of the Series B Preferred Stock, while shares of Series B Preferred Stock are issued and outstanding,
holders of Series B Preferred Stock shall be entitled to receive, and the Company shall pay, dividends on shares of Series B Preferred
Stock equal (on an as-if-converted-to-Common-Stock basis and without regard to any limitations on conversion set forth herein or otherwise)
to and in the same form as dividends (which shall be made in accordance with the terms of the Certificate of Designation) actually paid
on shares of the Company&rsquo;s Common Stock (the &ldquo;<U>Common Stock</U>&rdquo;) when, as and if such dividends (which shall be made
in accordance with the terms of the Certificate of Designation) are paid on shares of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I><U>Voting Rights</U></I>.
Subject to certain limitations described in the Certificate of Designation, the Series B Preferred Stock is voting stock. The issuance
of preferred stock has limited voting power, such that the preferred stock would vote as if converted at the &ldquo;Nasdaq Minimum Price&rdquo;
as defined in Listing Rule 5635(d)(1), on the date of issuance. Notwithstanding the foregoing, the holders of the Series B Preferred Stock
shall not be permitted to vote in excess of 19.99% until shareholder approval for the Series B Preferred Stock is obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I><U>Liquidation</U></I>.
Upon any Liquidation (as defined in the Certificate of Designation), the assets of the Company available for distribution to its stockholders
shall be distributed among the holders of the shares of the Company&rsquo;s Series A Convertible Preferred Stock, Series B Preferred Stock
and Common Stock, pro rata based on the number of shares held by each such holder, treating for this purpose all shares of Series B Preferred
Stock as if they had been converted to Common Stock pursuant to the terms of the Certificate of Designation immediately prior to such
Liquidation, without regard to any limitations on conversion set forth in the Certificate of Designation or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> <I><U>Conversion</U>.&nbsp;</I>Subject
to the limitations set forth in the Certificate of Designation, at the option of the holder, each share of Series B Preferred Stock shall
be convertible into a number shares of Common Stock obtained by dividing the Stated Value of each such share of Series B Preferred Stock
by the Floor Price of $0.20 (the &ldquo;Floor <U>Price</U>&rdquo;). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Delaware Anti-Takeover Statute</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the provisions of Section&nbsp;203
of the DGCL (&ldquo;Section&nbsp;203&rdquo;) regulating corporate takeovers. In general, Section&nbsp;203 prohibits a publicly held Delaware
corporation from engaging, under certain circumstances, in a business combination with an interested stockholder for a period of three&nbsp;years
following the date the person became an interested stockholder unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">prior to
                                            the date of the transaction, the board of directors of the corporation approved either the
                                            business combination or the transaction which resulted in the stockholder becoming an interested
                                            stockholder;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">upon completion
                                            of the transaction that resulted in the stockholder becoming an interested stockholder, the
                                            interested stockholder owned at least 85% of the voting stock of the corporation outstanding
                                            at the time the transaction commenced, excluding for purposes of determining the voting stock
                                            outstanding, the outstanding voting stock owned by the interested stockholder, (1)&nbsp;shares
                                            owned by persons who are directors and also officers and (2)&nbsp;shares owned by employee
                                            stock plans in which employee participants do not have the right to determine confidentially
                                            whether shares held subject to the plan will be tendered in a tender or exchange offer; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">at or subsequent
                                            to the date of the transaction, the business combination is approved by the board of directors
                                            of the corporation and authorized at an annual or special meeting of stockholders, and not
                                            by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting
                                            stock which is not owned by the interested stockholder.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, a business combination includes a
merger, asset, stock sale or other transaction resulting in a financial benefit to the interested stockholder. An interested stockholder
is a person who, together with affiliates and associates, owns or, within three&nbsp;years prior to the determination of interested stockholder
status, did own 15% or more of a corporation&rsquo;s outstanding voting stock. We expect the existence of Section&nbsp;203 to have an
anti-takeover effect with respect to transactions our Board of Directors does not approve in advance. We also anticipate that Section&nbsp;203
may discourage business combinations or other attempts that might result in a premium over the market price for the shares of common
stock held by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is listed for trading on The
Nasdaq Capital Market under the symbol &ldquo;SGBX.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent and registrar for our Common
Stock is Equiniti Trust Company, LLC.&nbsp;The transfer agent&rsquo;s principal business address is 48 Wall Street, Floor&nbsp;23, New&nbsp;York,
New&nbsp;York 10005, and its telephone number is (800)&nbsp;468-9716.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The validity of the shares of Common Stock
being offered by this prospectus have been passed upon for us by Sichenzia Ross Ference Carmel LLP. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements as of and
for the year ended December 31, 2024, incorporated by reference in this prospectus and the registration statement have been so incorporated
in reliance on the report of M&amp;K CPAS PLLC, an independent registered public accounting firm, incorporated by reference, given on
the authority of said firm as experts in auditing and accounting. The consolidated financial statements as of and for the year ended December
31, 2023, incorporated by reference in this prospectus and the registration statement have been so incorporated in reliance on the report
of M&amp;K CPAS PLLC, an independent registered public accounting firm, incorporated by reference, given on the authority of said firm
as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_013"></A><B>WHERE YOU CAN FIND ADDITIONAL
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a reporting company and file annual, quarterly
and current reports, proxy statements and other information with the SEC.&nbsp;We have filed with the SEC a registration statement on
Form&nbsp;S-1 under the Securities Act with respect to the securities we are offering to sell. This prospectus, which constitutes part
of the registration statement, does not include all of the information contained in the registration statement and the exhibits, schedules
and amendments to the registration statement. For further information with respect to us and our Common Stock, we refer you to the registration
statement and to the exhibits and schedules to the registration statement. Statements contained in this prospectus about the contents
of any contract, agreement or other document are not necessarily complete, and, in each instance, we refer you to the copy of the contract,
agreement or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects
by this reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC maintains an Internet website, which
is located at <I>www.sec.gov</I>, that contains reports, proxy and information statements and other information regarding issuers that
file electronically with the SEC.&nbsp;You may access the registration statement of which this prospectus is a part at the SEC&rsquo;s
Internet website. Upon completion of this offering, we will be subject to the information reporting requirements of the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934,
as amended, and we will file reports, proxy statements and other information with the SEC.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>INCORPORATION OF CERTAIN
DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC allows us to &ldquo;incorporate by reference&rdquo;
the information we file with it which means that we can disclose important information to you by referring you to those documents instead
of having to repeat the information in this prospectus. The information incorporated by reference is considered to be part of this prospectus,
and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference
the documents listed below and any future filings made with the SEC (other than any portions of any such documents that are not deemed
&ldquo;filed&rdquo; under the Exchange&nbsp;Act in accordance with the Exchange&nbsp;Act and applicable SEC rules) under Sections 13(a),
13(c), 14 or 15(d)&nbsp;of the Exchange&nbsp;Act including those made after (i)&nbsp;the date of the registration statement of which
this prospectus is a part and prior to effectiveness of the registration statement and (ii)&nbsp;the date of this prospectus and before
the completion of the offering of the shares of our Common Stock included in this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Our Annual
                                            Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025026495/sgbx-20241231.htm">Form&nbsp;10-K</A>
                                            for the year ended December&nbsp;31, 2024 (File No.&nbsp;001-38037) filed with the SEC on
                                            April 1, 2025;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Quarterly Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1023994/000121390025076841/ea0252974-10q_safe.htm">Form 10-Q</A> or the quarter ended June 30, 2025, filed with the SEC on August 14, 2025; </FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">Our
                                            Current Reports on Form&nbsp;8-K filed with the SEC on January&nbsp;17, 2025, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025003259/ea0227602-8k_safeandgreen.htm">January&nbsp;14,
                                            2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025004768/ea0228133-8k_safeandgreen.htm">January&nbsp;21,
                                            2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025006735/ea0228778-8k_safe.htm">January
                                            27, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025007674/ea0229068-8k_safe.htm">January
                                            29, 2025</A>, both 8-K&rsquo;s filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025009469/ea0229729-8k_safe.htm">February&nbsp;3, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025015448/ea0231543-8k_safe.htm">February&nbsp;20,
                                            2025</A></FONT>, <FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025016633/ea0231947-8k_safe.htm">February&nbsp;24,
                                            2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025018329/ea0232486-8k_safe.htm">February&nbsp;28,
                                            2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025022185/ea0233730-8k_safe.htm">March&nbsp;10,
                                            2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025027595/ea0236831-8k_safe.htm">April
                                            2, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025030095/ea0237670-8k_safe.htm">April&nbsp;9,
                                            2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025032574/ea0238475-8k_safe.htm">April
                                            16, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025032675/ea0238610-8k_safe.htm">April
                                            17, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025044947/ea0242563-8k_safe.htm">May
                                            16, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025046596/ea0243183-8k_safe.htm">May
                                            22, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025048548/ea0243768-8k_safe.htm">May
                                            29, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025049692/ea0244181-8k_safe.htm">June
                                            2, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025051299/ea0244754-8k_safe.htm">June
                                            5, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025052773/ea0245203-8k_safe.htm">June
                                            10, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025053920/ea0245628-8k_safe.htm">June
                                            12, 2025</A>,  <A HREF="https://www.sec.gov/Archives/edgar/data/1023994/000121390025065539/ea0249197-8k_safe.htm">July
                                            18, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025071746/ea0251791-8k_safe.htm">August 5, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025080739/ea0254659-8k_safe.htm">August 26, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025086479/ea0256834-8k_safe.htm">September 10, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025088298/ea0257651-8k_safe.htm">September 17, 2025</A> (File Nos.&nbsp;001-38037); and</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The description
                                            of the Registrant&rsquo;s Common Stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390017002571/f8a12b0317_sgblocksinc.htm">Form&nbsp;8-A</A>
                                            filed under the Exchange&nbsp;Act, as filed on March&nbsp;20, 2017 (File No.&nbsp;001-38037),
                                            including any amendment or report filed for the purpose of updating such description, as
                                            updated by the description of the Common Stock filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390024040541/ex49_1.htm">Exhibit
                                            4.9</A> to our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390025026495/sgbx-20241231.htm">Form&nbsp;10-K</A>
                                            for the year ended December&nbsp;31, 2024 filed with the SEC on April 1, 2025, including
                                            any amendments or reports filed for the purpose of updating such description.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statement contained in this prospectus or
any prospectus supplement, or in a document incorporated or deemed to be incorporated by reference herein or therein, shall be deemed
to be modified or superseded to the extent that a statement contained herein, or in any subsequent prospectus supplement or in any subsequently
filed document that also is incorporated or deemed to be incorporated by reference herein or therein, modifies or supersedes such statement.
Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus
or any prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may obtain, free of charge, a copy of any
of these documents (other than exhibits to these documents unless the exhibits are specifically incorporated by reference into these
documents or referred to in this prospectus) from our website (<I>www.safeandgreenholdings.com</I>) or by writing or calling us at the
following address and telephone number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Safe&nbsp;&amp; Green Holdings Corp.<BR>
990 Biscayne Blvd., Suite 501<BR>
Miami, Florida 33132<BR>
(646)&nbsp;240-4235</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should rely only on information contained
in, or incorporated by reference into, this prospectus and any prospectus supplement. We have not authorized anyone to provide you with
information different from that contained in this prospectus or incorporated by reference into this prospectus. We are not making offers
to sell the securities in any jurisdiction in which such an offer or solicitation is not authorized or in which the person making such
offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_001.jpg" ALT="" STYLE="width: 120px; height: 119px"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>Safe &amp; Green Holdings Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>937,500 Shares of Common Stock</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>October 1, 2025</B></P>
<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>











</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #R /0# 2(  A$! Q$!_\0
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M>RR2:#X(\/%V%OIVFVR] ,#_ .N37A_BK]H:\FFD@\-6BPPC(%Q.,L?<+VH
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M=6GS2'!W5PHI>U)746+G%31ODXJ&@$@\4 6\48H0[@*=B@#[2\#?\D_\-_\
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M44 %+DCN:2B@!=S>I_.DHHH **** "BBB@ HHQ10 4444 %%%% !2BDJ110
ML:Y-74<*,5 I '%.H&6!SS2D5#&Q J3=F@M'V=X(_P"1!\.?]@NV_P#12T4G
M@C_D0?#G_8+MO_12T4&9X7^T'_R/MC_V"X__ $;+7D]>K_M"?\C[8_\ 8+C_
M /1LM>3;J"TQW>KEM)D8)K/+4J,0P(I#N:CHL@PPK-N;3RVW*#BK\4F].>M2
M8W#&*I"9S\@PM1'K6S/9!E)4<UFR6[(<$46)*])4C)@5'2$%% I2* $HHHH
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M&07)^E:4:1Q#";0*?N7^\*8QD<"1#"BI13=R_P!X?G3MZ_WA^=,!:44W>O\
M>'YTFY?[P_.E8I"21JXPPJG+9CJIJ\64_P 0_.DW)_>% [HQY$*=:@:MUUB<
M8.VJ<ME'R58?G0)GV#X&_P"2?^&_^P7:_P#HI:*=X)&WP%X=7TTRV'_D):*1
M!NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
